-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IYEU4Yzes2XtmPoveofgc5VN1GNPX48uZtvRLq+55166MxT2JimCCPyQ346qLP6h Zg7XE1HLiZ0DAnW8lhByEQ== 0001209191-08-029621.txt : 20080513 0001209191-08-029621.hdr.sgml : 20080513 20080513164904 ACCESSION NUMBER: 0001209191-08-029621 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080509 FILED AS OF DATE: 20080513 DATE AS OF CHANGE: 20080513 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000010081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221927534 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 SUMMIT AVE CITY: MONTVALE STATE: NJ ZIP: 07645-1523 BUSINESS PHONE: 201-930-3300 MAIL ADDRESS: STREET 1: 225 SUMMIT AVE CITY: MONTVALE STATE: NJ ZIP: 07645-1523 FORMER COMPANY: FORMER CONFORMED NAME: BARR LABORATORIES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KILLION FREDERICK CENTRAL INDEX KEY: 0001237261 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09860 FILM NUMBER: 08828152 BUSINESS ADDRESS: STREET 1: BARR LABORATORIES INC STREET 2: 300 CORPORATE DRIVE SUITE 10 CITY: BLAUVELT STATE: NY ZIP: 10913 BUSINESS PHONE: 18002275227 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2008-05-09 0 0000010081 BARR PHARMACEUTICALS INC BRL 0001237261 KILLION FREDERICK BARR PHARMACEUTICALS, INC. 225 SUMMIT AVENUE MONTVALE NJ 07645 0 1 0 0 General Counsel Common Stock 2008-05-09 4 A 0 10000 30.1867 A 11589 D Incentive Stock Options 30.1867 2009-05-09 4 S 0 10000 0.00 D 2012-03-01 Common Stock 10000 6560 D 3,312 vested on 3/1/2003 3,312 vested on 3/1/2004 3,312 vested on 3/1/2005 64 vested on 3/1/2006 S/S William T McKee as Attorney-in-Fact for Frederick Killion 2008-05-13 -----END PRIVACY-ENHANCED MESSAGE-----